Emerging roles of long non‐coding RNA in cancer
Since comprehensive analysis of the mammalian genome revealed that the majority of genomic products are transcribed in long non‐coding RNA (lncRNA), increasing attention has been paid to these transcripts. The applied next‐generation sequencing technologies have provided accumulating evidence of dys...
Uloženo v:
| Vydáno v: | Cancer science Ročník 109; číslo 7; s. 2093 - 2100 |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
England
John Wiley & Sons, Inc
01.07.2018
John Wiley and Sons Inc |
| Témata: | |
| ISSN: | 1347-9032, 1349-7006, 1349-7006 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Since comprehensive analysis of the mammalian genome revealed that the majority of genomic products are transcribed in long non‐coding RNA (lncRNA), increasing attention has been paid to these transcripts. The applied next‐generation sequencing technologies have provided accumulating evidence of dysregulated lncRNA in cancer. The implication of this finding can be seen in many forms and at multiple levels. With impacts ranging from integrating chromatin remodeling complexes to regulating transcription and post‐transcriptional processes, aberrant expression of lncRNA may have repercussions in cell proliferation, tumor progression or metastasis. lncRNA may act as enhancers, scaffolds or decoys by physically interacting with other RNA species or proteins, resulting in a direct impact on cell signaling cascades. Even though their functional classification is well‐established in the context of cancer, clearer characterization in terms of their phenotypic outputs is needed to optimize and identify suitable candidates that enable the development of new therapeutic strategies and the design of novel diagnostic approaches. The present article aims to outline different cancer‐associated lncRNA according to their contribution to tumor suppression or tumor promotion based on their most current functional annotations.
lncRNAs involved in tumor plasticity. Aberrantly expressed lncRNAs may have an important impact in the EMT‐MET processes by interacting with diverse signaling cascades. |
|---|---|
| AbstractList | Since comprehensive analysis of the mammalian genome revealed that the majority of genomic products are transcribed in long non-coding RNA (lncRNA), increasing attention has been paid to these transcripts. The applied next-generation sequencing technologies have provided accumulating evidence of dysregulated lncRNA in cancer. The implication of this finding can be seen in many forms and at multiple levels. With impacts ranging from integrating chromatin remodeling complexes to regulating transcription and post-transcriptional processes, aberrant expression of lncRNA may have repercussions in cell proliferation, tumor progression or metastasis. lncRNA may act as enhancers, scaffolds or decoys by physically interacting with other RNA species or proteins, resulting in a direct impact on cell signaling cascades. Even though their functional classification is well-established in the context of cancer, clearer characterization in terms of their phenotypic outputs is needed to optimize and identify suitable candidates that enable the development of new therapeutic strategies and the design of novel diagnostic approaches. The present article aims to outline different cancer-associated lncRNA according to their contribution to tumor suppression or tumor promotion based on their most current functional annotations. Since comprehensive analysis of the mammalian genome revealed that the majority of genomic products are transcribed in long non‐coding RNA (lnc RNA ), increasing attention has been paid to these transcripts. The applied next‐generation sequencing technologies have provided accumulating evidence of dysregulated lnc RNA in cancer. The implication of this finding can be seen in many forms and at multiple levels. With impacts ranging from integrating chromatin remodeling complexes to regulating transcription and post‐transcriptional processes, aberrant expression of lnc RNA may have repercussions in cell proliferation, tumor progression or metastasis. lnc RNA may act as enhancers, scaffolds or decoys by physically interacting with other RNA species or proteins, resulting in a direct impact on cell signaling cascades. Even though their functional classification is well‐established in the context of cancer, clearer characterization in terms of their phenotypic outputs is needed to optimize and identify suitable candidates that enable the development of new therapeutic strategies and the design of novel diagnostic approaches. The present article aims to outline different cancer‐associated lnc RNA according to their contribution to tumor suppression or tumor promotion based on their most current functional annotations. Since comprehensive analysis of the mammalian genome revealed that the majority of genomic products are transcribed in long non‐coding RNA (lncRNA), increasing attention has been paid to these transcripts. The applied next‐generation sequencing technologies have provided accumulating evidence of dysregulated lncRNA in cancer. The implication of this finding can be seen in many forms and at multiple levels. With impacts ranging from integrating chromatin remodeling complexes to regulating transcription and post‐transcriptional processes, aberrant expression of lncRNA may have repercussions in cell proliferation, tumor progression or metastasis. lncRNA may act as enhancers, scaffolds or decoys by physically interacting with other RNA species or proteins, resulting in a direct impact on cell signaling cascades. Even though their functional classification is well‐established in the context of cancer, clearer characterization in terms of their phenotypic outputs is needed to optimize and identify suitable candidates that enable the development of new therapeutic strategies and the design of novel diagnostic approaches. The present article aims to outline different cancer‐associated lncRNA according to their contribution to tumor suppression or tumor promotion based on their most current functional annotations. lncRNAs involved in tumor plasticity. Aberrantly expressed lncRNAs may have an important impact in the EMT‐MET processes by interacting with diverse signaling cascades. Since comprehensive analysis of the mammalian genome revealed that the majority of genomic products are transcribed in long non-coding RNA (lncRNA), increasing attention has been paid to these transcripts. The applied next-generation sequencing technologies have provided accumulating evidence of dysregulated lncRNA in cancer. The implication of this finding can be seen in many forms and at multiple levels. With impacts ranging from integrating chromatin remodeling complexes to regulating transcription and post-transcriptional processes, aberrant expression of lncRNA may have repercussions in cell proliferation, tumor progression or metastasis. lncRNA may act as enhancers, scaffolds or decoys by physically interacting with other RNA species or proteins, resulting in a direct impact on cell signaling cascades. Even though their functional classification is well-established in the context of cancer, clearer characterization in terms of their phenotypic outputs is needed to optimize and identify suitable candidates that enable the development of new therapeutic strategies and the design of novel diagnostic approaches. The present article aims to outline different cancer-associated lncRNA according to their contribution to tumor suppression or tumor promotion based on their most current functional annotations.Since comprehensive analysis of the mammalian genome revealed that the majority of genomic products are transcribed in long non-coding RNA (lncRNA), increasing attention has been paid to these transcripts. The applied next-generation sequencing technologies have provided accumulating evidence of dysregulated lncRNA in cancer. The implication of this finding can be seen in many forms and at multiple levels. With impacts ranging from integrating chromatin remodeling complexes to regulating transcription and post-transcriptional processes, aberrant expression of lncRNA may have repercussions in cell proliferation, tumor progression or metastasis. lncRNA may act as enhancers, scaffolds or decoys by physically interacting with other RNA species or proteins, resulting in a direct impact on cell signaling cascades. Even though their functional classification is well-established in the context of cancer, clearer characterization in terms of their phenotypic outputs is needed to optimize and identify suitable candidates that enable the development of new therapeutic strategies and the design of novel diagnostic approaches. The present article aims to outline different cancer-associated lncRNA according to their contribution to tumor suppression or tumor promotion based on their most current functional annotations. |
| Author | Sanchez Calle, Anna Kawamura, Yumi Yamamoto, Yusuke Takeshita, Fumitaka Ochiya, Takahiro |
| AuthorAffiliation | 1 Division of Molecular and Cellular Medicine National Cancer Center Research Institute Tokyo Japan 3 Department of Functional Analysis FIOC National Cancer Center Research Institute Tokyo Japan 4 Institute of Medical Science Tokyo Medical University Tokyo Japan 2 Ph.D. Program in Human Biology School of Integrative and Global Majors University of Tsukuba Tsukuba Japan |
| AuthorAffiliation_xml | – name: 2 Ph.D. Program in Human Biology School of Integrative and Global Majors University of Tsukuba Tsukuba Japan – name: 1 Division of Molecular and Cellular Medicine National Cancer Center Research Institute Tokyo Japan – name: 3 Department of Functional Analysis FIOC National Cancer Center Research Institute Tokyo Japan – name: 4 Institute of Medical Science Tokyo Medical University Tokyo Japan |
| Author_xml | – sequence: 1 givenname: Anna orcidid: 0000-0002-1127-5822 surname: Sanchez Calle fullname: Sanchez Calle, Anna organization: National Cancer Center Research Institute – sequence: 2 givenname: Yumi orcidid: 0000-0001-8386-4645 surname: Kawamura fullname: Kawamura, Yumi organization: University of Tsukuba – sequence: 3 givenname: Yusuke surname: Yamamoto fullname: Yamamoto, Yusuke organization: National Cancer Center Research Institute – sequence: 4 givenname: Fumitaka surname: Takeshita fullname: Takeshita, Fumitaka organization: National Cancer Center Research Institute – sequence: 5 givenname: Takahiro orcidid: 0000-0002-0776-9918 surname: Ochiya fullname: Ochiya, Takahiro email: tochiya@ncc.go.jp organization: Tokyo Medical University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29774630$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kctKQzEQhoNUtF4WvoAccKOLam7mJBuhlHoBUVD3IaZzauQ0qUmrdOcj-Iw-iTm2ihbNIpkw3_zzJ7OBWj54QGiH4EOS15E16ZAwwekKahPGVafEWLQ-47KjMKPraCOlR4wzo_gaWqeqLLlguI1IfwRx6PywiKGGVISqqEO-5Q7vr282DJrUzVW3cL6wxluIW2i1MnWC7cW5ie5O-3e9887l9dlFr3vZsceM0byXmBg1MJxaKo4xhsoysGAZk9WgzLEAKSQ1kt_LssJcESlVNlxKClSxTXQylx1P70cwsOAn0dR6HN3IxJkOxunfGe8e9DA8a4GpkpRlgf2FQAxPU0gTPXLJQl0bD2GaNMWcCJrbNejeEvoYptHn12lKueRKcEYytfvT0beVr8_MwNEcsDGkFKHS1k3MxIXGoKs1wboZl87j0p_jyhUHSxVfon-xC_UXV8Psf1D3urfzig-sC6Jb |
| CitedBy_id | crossref_primary_10_1016_j_canlet_2019_01_046 crossref_primary_10_1007_s10815_022_02446_8 crossref_primary_10_1186_s12935_020_01403_8 crossref_primary_10_3892_ol_2021_13079 crossref_primary_10_3390_epigenomes8010005 crossref_primary_10_3389_fgene_2018_00629 crossref_primary_10_3389_fbioe_2019_00439 crossref_primary_10_1016_j_gene_2020_145224 crossref_primary_10_1155_2023_7097909 crossref_primary_10_1080_15257770_2021_1956530 crossref_primary_10_1111_jcmm_18068 crossref_primary_10_3389_fcell_2025_1573723 crossref_primary_10_1186_s12935_022_02767_9 crossref_primary_10_1002_cbin_11597 crossref_primary_10_1016_j_biopha_2023_114807 crossref_primary_10_1155_2021_1736819 crossref_primary_10_1007_s12041_019_1076_3 crossref_primary_10_1016_j_genrep_2020_100992 crossref_primary_10_1002_iub_2710 crossref_primary_10_1016_j_prp_2021_153475 crossref_primary_10_1186_s12863_021_01015_9 crossref_primary_10_1097_CAD_0000000000000882 crossref_primary_10_2147_CMAR_S277399 crossref_primary_10_1016_j_ygeno_2024_110957 crossref_primary_10_3390_cancers13030379 crossref_primary_10_3390_cancers13081976 crossref_primary_10_1186_s12935_020_01657_2 crossref_primary_10_1016_j_heliyon_2024_e32245 crossref_primary_10_1080_14737159_2021_1996227 crossref_primary_10_1186_s13058_020_01295_6 crossref_primary_10_3389_fgene_2019_01346 crossref_primary_10_1080_08923973_2022_2090954 crossref_primary_10_3892_ol_2019_11217 crossref_primary_10_1096_fj_202000732RR crossref_primary_10_1038_s41598_022_24023_w crossref_primary_10_3389_fgene_2022_989646 crossref_primary_10_3389_fonc_2019_00649 crossref_primary_10_1007_s12094_023_03197_3 crossref_primary_10_1016_j_omtn_2022_03_012 crossref_primary_10_1002_iub_2778 crossref_primary_10_3389_fimmu_2022_880288 crossref_primary_10_2174_0109298673264372230919102758 crossref_primary_10_1177_09603271211038744 crossref_primary_10_1093_neuonc_noaa156 crossref_primary_10_1073_pnas_2017734117 crossref_primary_10_1186_s13045_018_0673_6 crossref_primary_10_1016_j_canlet_2020_11_038 crossref_primary_10_1111_cas_15370 crossref_primary_10_1002_jgm_3506 crossref_primary_10_3389_fonc_2019_01526 crossref_primary_10_1007_s00432_023_05118_x crossref_primary_10_4014_jmb_2106_06028 crossref_primary_10_1186_s12885_023_10937_9 crossref_primary_10_3389_fonc_2022_965628 crossref_primary_10_1186_s12943_020_01187_5 crossref_primary_10_3390_jcm8030282 crossref_primary_10_2147_PGPM_S247082 crossref_primary_10_1007_s12029_021_00733_8 crossref_primary_10_1186_s12890_021_01600_9 crossref_primary_10_1016_j_semcancer_2019_06_002 crossref_primary_10_3389_fonc_2019_00669 crossref_primary_10_2147_CMAR_S486875 crossref_primary_10_1016_j_virusres_2021_198594 crossref_primary_10_3389_fgene_2019_01155 crossref_primary_10_1007_s12672_025_03309_1 crossref_primary_10_1016_j_gene_2018_11_052 crossref_primary_10_1016_j_heliyon_2021_e06388 crossref_primary_10_1016_j_prp_2021_153550 crossref_primary_10_1186_s13568_025_01870_0 crossref_primary_10_1155_2020_7698590 crossref_primary_10_1002_cbin_11761 crossref_primary_10_1002_jcb_27712 crossref_primary_10_3389_fonc_2019_01549 crossref_primary_10_1111_cas_70074 crossref_primary_10_1007_s10238_021_00721_z crossref_primary_10_3390_antiox9040318 crossref_primary_10_3390_cancers11020265 crossref_primary_10_1093_biolre_ioab212 crossref_primary_10_1007_s00018_020_03632_6 crossref_primary_10_1242_jcs_259306 crossref_primary_10_3892_or_2021_8207 crossref_primary_10_1007_s00109_021_02075_1 crossref_primary_10_1016_j_heliyon_2024_e35208 crossref_primary_10_2147_OTT_S274623 crossref_primary_10_1089_cbr_2022_0031 crossref_primary_10_1155_2023_2733232 crossref_primary_10_1134_S0026893320050052 crossref_primary_10_1016_j_clinsp_2024_100400 crossref_primary_10_1007_s12094_023_03244_z crossref_primary_10_2217_bmm_2020_0136 crossref_primary_10_3389_fgene_2019_00446 crossref_primary_10_1097_MS9_0000000000002097 crossref_primary_10_1016_j_bbrc_2023_03_033 crossref_primary_10_1002_cai2_90 crossref_primary_10_1038_s41416_020_01091_1 crossref_primary_10_2147_CMAR_S352308 crossref_primary_10_3390_ijms241512103 crossref_primary_10_1016_j_taap_2021_115845 crossref_primary_10_3389_fgene_2021_754503 crossref_primary_10_3390_ijms21228855 crossref_primary_10_1186_s12859_020_03656_6 crossref_primary_10_1155_2023_5513245 crossref_primary_10_1016_j_bbrc_2019_04_203 crossref_primary_10_34172_bi_31211 crossref_primary_10_3892_ol_2022_13558 crossref_primary_10_1002_tox_23339 crossref_primary_10_1158_1541_7786_MCR_20_0282 crossref_primary_10_3892_ijo_2022_5334 crossref_primary_10_1007_s10142_022_00867_3 crossref_primary_10_1186_s12884_022_04716_w crossref_primary_10_2147_IJGM_S411511 crossref_primary_10_3389_fimmu_2022_740960 crossref_primary_10_1002_jcb_28514 crossref_primary_10_3390_biom13040684 crossref_primary_10_3389_fnins_2023_1182635 crossref_primary_10_1007_s12094_022_02944_2 crossref_primary_10_1038_s41434_020_00189_8 crossref_primary_10_3389_fcell_2020_599070 crossref_primary_10_1016_j_clinre_2021_101648 crossref_primary_10_1007_s13193_024_01992_0 crossref_primary_10_3390_ncrna5030047 crossref_primary_10_1111_jcmm_15973 crossref_primary_10_4018_IJDWM_317092 crossref_primary_10_1073_pnas_1903432116 crossref_primary_10_1155_2021_5525763 crossref_primary_10_3389_fonc_2021_628027 crossref_primary_10_3390_cancers14122819 crossref_primary_10_1016_j_heliyon_2023_e14811 crossref_primary_10_3389_fonc_2021_737867 crossref_primary_10_1155_2022_2337447 crossref_primary_10_3390_genes12091375 crossref_primary_10_1002_cac2_12254 crossref_primary_10_1186_s12935_020_01581_5 crossref_primary_10_1186_s12890_021_01657_6 crossref_primary_10_1016_j_phrs_2022_106462 crossref_primary_10_1093_bib_bbz118 crossref_primary_10_1111_jcmm_15746 crossref_primary_10_1016_j_ejphar_2021_174114 crossref_primary_10_1002_1878_0261_12704 crossref_primary_10_1002_cam4_4471 crossref_primary_10_1038_s41598_022_10508_1 crossref_primary_10_1007_s10815_023_02937_2 crossref_primary_10_3389_fonc_2022_1014949 crossref_primary_10_3389_fonc_2021_645832 crossref_primary_10_1038_s41598_019_42107_y crossref_primary_10_3390_cancers15061800 crossref_primary_10_1016_j_surg_2019_06_052 crossref_primary_10_4081_ejh_2021_3224 crossref_primary_10_1038_s41420_023_01718_1 crossref_primary_10_1016_j_biopha_2024_117458 crossref_primary_10_1111_jcmm_15673 crossref_primary_10_1134_S1022795424700029 crossref_primary_10_1007_s11010_023_04748_6 crossref_primary_10_3892_ol_2020_11558 crossref_primary_10_1186_s12931_025_03122_y crossref_primary_10_1016_j_cellsig_2019_109379 crossref_primary_10_1007_s10620_020_06581_z crossref_primary_10_1002_cmdc_202200422 crossref_primary_10_1016_j_mgene_2020_100691 crossref_primary_10_1186_s12935_022_02825_2 crossref_primary_10_1016_j_lfs_2022_120810 crossref_primary_10_1111_jcmm_14359 crossref_primary_10_2147_IJGM_S381027 crossref_primary_10_1155_2022_9316847 crossref_primary_10_7717_peerj_16197 crossref_primary_10_1038_s41419_020_02853_8 crossref_primary_10_1016_j_yexmp_2019_104353 crossref_primary_10_1111_1759_7714_13228 crossref_primary_10_1007_s00432_022_03981_8 crossref_primary_10_3389_fvets_2021_722432 crossref_primary_10_1097_MD_0000000000026834 crossref_primary_10_1016_j_ygeno_2021_06_029 crossref_primary_10_2147_CMAR_S267665 crossref_primary_10_2147_CMAR_S281608 crossref_primary_10_1016_j_heliyon_2023_e22595 crossref_primary_10_1186_s13048_021_00829_6 crossref_primary_10_1016_j_prp_2018_11_015 crossref_primary_10_1007_s12672_025_02912_6 crossref_primary_10_3389_fcell_2021_626020 crossref_primary_10_1016_j_mcp_2022_101866 crossref_primary_10_3389_fonc_2020_00785 crossref_primary_10_1016_j_bcp_2021_114469 crossref_primary_10_3390_life14111430 crossref_primary_10_1016_j_ijbiomac_2019_01_157 crossref_primary_10_1016_j_ygyno_2021_02_004 crossref_primary_10_1177_03946320221103195 crossref_primary_10_3390_genes15010087 crossref_primary_10_1080_15257770_2022_2065017 crossref_primary_10_1186_s40364_022_00368_2 crossref_primary_10_1016_j_mcp_2023_101909 crossref_primary_10_3389_fgene_2022_885391 crossref_primary_10_3389_bjbs_2023_11103 crossref_primary_10_1007_s11033_021_06603_7 crossref_primary_10_1016_j_canlet_2021_04_016 crossref_primary_10_1186_s12915_023_01521_5 crossref_primary_10_1002_iub_2001 crossref_primary_10_3389_fonc_2020_00656 crossref_primary_10_1042_BSR20202444 crossref_primary_10_1186_s12967_021_03026_7 crossref_primary_10_1159_000527370 crossref_primary_10_1007_s12672_024_00929_x crossref_primary_10_3892_ijo_2019_4895 crossref_primary_10_1007_s00432_023_05047_9 crossref_primary_10_2147_OTT_S245710 crossref_primary_10_1097_MD_0000000000018868 crossref_primary_10_2147_CMAR_S286205 crossref_primary_10_3390_labmed2030017 crossref_primary_10_3389_fcell_2021_731042 crossref_primary_10_1186_s13046_021_01943_5 crossref_primary_10_1186_s12885_023_11347_7 crossref_primary_10_1016_j_bbrc_2020_03_151 crossref_primary_10_2174_0109298673318929240829065611 crossref_primary_10_1002_2211_5463_13061 crossref_primary_10_1111_1346_8138_17133 crossref_primary_10_1016_j_pharmthera_2020_107492 crossref_primary_10_1186_s13578_021_00689_z crossref_primary_10_3389_fgene_2021_763281 crossref_primary_10_1177_1533033819843889 crossref_primary_10_3390_cancers12051197 crossref_primary_10_3390_cells11152448 crossref_primary_10_1002_jcb_29447 crossref_primary_10_3390_ijms21155311 crossref_primary_10_3389_fonc_2022_781903 crossref_primary_10_1038_s41417_021_00309_5 crossref_primary_10_1097_CAD_0000000000001385 crossref_primary_10_1016_j_tice_2022_101769 crossref_primary_10_1111_1756_185X_70035 crossref_primary_10_3389_fphar_2023_1167418 crossref_primary_10_1002_jbt_70012 crossref_primary_10_1186_s12885_020_07149_w crossref_primary_10_1007_s11033_021_06818_8 crossref_primary_10_1016_j_cca_2018_10_002 crossref_primary_10_1016_j_prp_2023_154403 crossref_primary_10_1038_s41420_022_01060_y crossref_primary_10_1080_15384101_2021_2015670 crossref_primary_10_1007_s12010_021_03520_0 crossref_primary_10_1016_j_intimp_2024_112063 crossref_primary_10_3389_fgene_2020_611823 crossref_primary_10_1007_s40618_021_01543_2 crossref_primary_10_2147_IJGM_S344771 crossref_primary_10_2147_CMAR_S270087 crossref_primary_10_1155_2022_9916228 crossref_primary_10_1177_11782234231184378 crossref_primary_10_2174_0113816128254674230925040033 crossref_primary_10_1186_s12885_023_11084_x crossref_primary_10_3389_fmolb_2019_00113 crossref_primary_10_1080_21691401_2019_1671431 crossref_primary_10_3892_etm_2021_10618 crossref_primary_10_1038_s41419_020_03029_0 crossref_primary_10_3390_cancers14225590 crossref_primary_10_1007_s11010_022_04384_6 crossref_primary_10_3390_ijms23095271 crossref_primary_10_1111_cbdd_14200 crossref_primary_10_1016_j_yexcr_2023_113686 crossref_primary_10_1186_s13058_021_01450_7 crossref_primary_10_1016_j_phymed_2021_153830 crossref_primary_10_1002_cam4_2867 crossref_primary_10_1007_s10528_023_10424_7 crossref_primary_10_1186_s12967_024_05732_4 crossref_primary_10_1016_j_oooo_2022_01_006 crossref_primary_10_3389_fcell_2022_982439 crossref_primary_10_3389_fonc_2021_650054 crossref_primary_10_2147_OTT_S257738 crossref_primary_10_1080_21655979_2021_1953216 crossref_primary_10_1038_s41419_021_03594_y crossref_primary_10_1016_j_bbcan_2021_188513 crossref_primary_10_1155_2022_2295044 crossref_primary_10_1515_med_2021_0314 crossref_primary_10_3389_fneur_2020_573264 crossref_primary_10_3389_pore_2021_610159 crossref_primary_10_1139_bcb_2019_0435 crossref_primary_10_1007_s10495_020_01638_w crossref_primary_10_1042_BSR20210284 crossref_primary_10_1186_s12935_021_01988_8 crossref_primary_10_1111_jcmm_15163 crossref_primary_10_1016_j_archoralbio_2023_105762 crossref_primary_10_1038_s41417_020_00213_4 crossref_primary_10_1016_j_gene_2020_144604 crossref_primary_10_1016_j_biopha_2019_108798 crossref_primary_10_3389_fonc_2020_00038 crossref_primary_10_3389_fonc_2022_1008856 crossref_primary_10_3390_biom12121761 crossref_primary_10_1016_j_prp_2022_154245 crossref_primary_10_7717_peerj_15810 crossref_primary_10_1080_07391102_2023_2256408 crossref_primary_10_3389_fonc_2021_651693 crossref_primary_10_1155_2022_8307975 crossref_primary_10_1016_j_biopha_2020_110359 crossref_primary_10_1002_jcb_29331 crossref_primary_10_1089_gtmb_2023_0163 crossref_primary_10_1016_j_arcmed_2020_09_002 crossref_primary_10_1186_s12953_022_00187_1 crossref_primary_10_1186_s13046_021_02197_x crossref_primary_10_1080_14737159_2021_1979960 crossref_primary_10_1155_2021_5574130 crossref_primary_10_1016_j_tranon_2021_101065 crossref_primary_10_1038_s41598_024_51947_2 crossref_primary_10_3892_etm_2021_10783 crossref_primary_10_3390_ijms242417447 crossref_primary_10_3892_ijmm_2020_4471 crossref_primary_10_1007_s00432_022_04040_y crossref_primary_10_1155_2020_1216325 crossref_primary_10_1007_s10142_022_00855_7 crossref_primary_10_1158_0008_5472_CAN_22_0090 crossref_primary_10_1096_fj_201900078RR crossref_primary_10_3892_etm_2022_11171 crossref_primary_10_3390_ijms242015206 crossref_primary_10_1093_nargab_lqad072 crossref_primary_10_1177_1176935120969692 crossref_primary_10_3389_fgene_2022_1081478 crossref_primary_10_1080_10408398_2021_2001785 crossref_primary_10_1186_s12967_024_05397_z crossref_primary_10_1089_cbr_2021_0339 crossref_primary_10_1016_j_prp_2023_154381 crossref_primary_10_1016_j_cbi_2021_109622 crossref_primary_10_3390_ijms23020752 crossref_primary_10_1093_carcin_bgab077 crossref_primary_10_1007_s10637_019_00884_3 crossref_primary_10_1186_s13046_022_02452_9 crossref_primary_10_3390_genes10010052 crossref_primary_10_1016_j_heliyon_2024_e39857 crossref_primary_10_3892_ol_2019_11063 crossref_primary_10_1080_15257770_2024_2328732 crossref_primary_10_1002_jcb_28077 crossref_primary_10_2147_OTT_S242715 crossref_primary_10_1038_s41419_021_03690_z crossref_primary_10_1038_s41598_024_63943_7 crossref_primary_10_1515_med_2021_0231 crossref_primary_10_1002_mc_23109 crossref_primary_10_1126_sciadv_abe5708 crossref_primary_10_1186_s13046_019_1055_9 crossref_primary_10_1155_2021_9394563 crossref_primary_10_3892_or_2021_8116 crossref_primary_10_1186_s12905_024_02905_7 crossref_primary_10_3892_ol_2025_15239 crossref_primary_10_3390_ijerph19159648 crossref_primary_10_1007_s10585_022_10174_7 crossref_primary_10_1080_21655979_2021_1935404 crossref_primary_10_1002_iid3_1129 crossref_primary_10_3892_etm_2021_10587 crossref_primary_10_1016_j_lfs_2024_122850 crossref_primary_10_3390_cells12050810 crossref_primary_10_1155_2022_1987519 crossref_primary_10_1111_iep_70003 crossref_primary_10_3390_ncrna9010012 crossref_primary_10_1016_j_biopha_2020_110566 crossref_primary_10_3389_fonc_2019_01337 crossref_primary_10_1093_carcin_bgae019 crossref_primary_10_1007_s10147_020_01852_1 crossref_primary_10_2147_CMAR_S313744 crossref_primary_10_3389_fcell_2021_739509 crossref_primary_10_3389_fendo_2025_1527693 crossref_primary_10_1089_cbr_2019_3335 crossref_primary_10_1097_CAD_0000000000001327 crossref_primary_10_3390_biomedicines10102623 crossref_primary_10_1016_j_biopha_2020_110655 crossref_primary_10_1007_s10620_020_06200_x crossref_primary_10_1002_jbt_23052 crossref_primary_10_1080_21655979_2021_1946634 crossref_primary_10_1155_2021_9977695 crossref_primary_10_3390_ncrna9010016 crossref_primary_10_2217_pme_2022_0104 crossref_primary_10_1016_j_omtn_2019_09_005 crossref_primary_10_1002_cnr2_2114 crossref_primary_10_2217_epi_2018_0119 crossref_primary_10_1155_2022_3448224 crossref_primary_10_1186_s13045_022_01224_4 crossref_primary_10_4240_wjgs_v16_i3_842 crossref_primary_10_1007_s10528_023_10345_5 crossref_primary_10_1007_s10330_022_0581_1 crossref_primary_10_1016_j_ijbiomac_2024_129658 crossref_primary_10_1002_mc_23155 crossref_primary_10_1016_j_semcancer_2020_12_013 crossref_primary_10_1186_s12885_021_09059_x crossref_primary_10_1007_s10735_021_09969_x crossref_primary_10_1097_MD_0000000000030531 crossref_primary_10_3389_fphys_2019_00369 crossref_primary_10_3389_fpubh_2022_902445 crossref_primary_10_3390_genes12030395 crossref_primary_10_1016_j_bbrc_2018_08_174 crossref_primary_10_3390_cancers13030570 crossref_primary_10_3389_fmolb_2021_781307 crossref_primary_10_3390_cells11081346 crossref_primary_10_1042_BSR20202298 crossref_primary_10_1080_02713683_2021_1984536 crossref_primary_10_1371_journal_pone_0308009 crossref_primary_10_3389_fnmol_2019_00293 crossref_primary_10_24875_RIC_23000235 crossref_primary_10_3389_fonc_2020_561833 crossref_primary_10_1186_s12885_021_08798_1 crossref_primary_10_1186_s41021_021_00193_3 crossref_primary_10_1007_s13577_022_00837_8 crossref_primary_10_1155_2022_3855462 crossref_primary_10_1016_j_lfs_2020_118725 crossref_primary_10_1097_CAD_0000000000001124 crossref_primary_10_1016_j_bbrc_2020_09_115 crossref_primary_10_3389_fonc_2023_1156663 |
| Cites_doi | 10.1136/jclinpath-2015-203275 10.1159/000464465 10.1038/bjc.2013.698 10.1111/hepr.12659 10.3727/096504018x15190844870055 10.1158/0008-5472.CAN-15-2018 10.1038/sj.onc.1209846 10.1111/j.1755-148X.2010.00748.x 10.1074/jbc.M116.750950 10.1016/j.celrep.2012.06.003 10.1016/j.ccr.2007.07.027 10.1038/nature13311 10.3892/or.2015.4397 10.1038/ng.840 10.1007/s10238-015-0396-8 10.1038/nature13182 10.18632/oncotarget.11709 10.1038/nrm3679 10.1111/apm.12555 10.1002/pros.20158 10.1038/srep38414 10.1007/s12307-014-0158-2 10.1038/ncomms7520 10.3892/or.2014.3047 10.1007/s00335-015-9593-8 10.1038/ng.3702 10.18632/oncotarget.23343 10.1158/1541-7786.MCR-17-0207 10.1016/j.bbagrm.2015.11.008 10.1038/nature11233 10.18632/oncotarget.9622 10.1200/JCO.2007.13.1904 10.1016/j.cell.2015.12.017 10.1158/0008-5472.CAN-12-2850 10.18632/oncotarget.5880 10.1101/cshperspect.a000687 10.1101/gad.270959.115 10.1038/ng.3192 10.1080/15384047.2015.1108496 10.1016/j.clcc.2013.06.003 10.1016/j.tig.2016.04.002 10.18632/oncotarget.5728 10.1038/onc.2016.260 10.1016/j.biomaterials.2014.12.023 10.1016/j.leukres.2009.06.019 10.18632/oncotarget.4737 10.1177/1533034617700559 10.1186/s12943-018-0758-4 10.1016/j.cell.2013.06.020 10.1016/j.molcel.2014.04.025 10.1038/bjc.2014.383 10.1101/gad.284661.116 10.1038/srep34043 10.1038/nature08975 10.1039/c2mb25386k 10.1038/s41556-018-0066-7 10.1007/s10549-017-4160-5 10.1016/j.molcel.2010.08.011 10.1038/nature09144 10.1016/j.urolonc.2018.02.019 10.3390/cancers3010994 10.1038/ng.3673 10.1016/j.gene.2014.11.060 10.1177/1010428317727539 10.1038/s41467-017-01781-0 10.15252/embj.201695335 10.1038/nm.4135 10.18632/oncotarget.19130 10.1007/s13277-015-4773-4 10.1038/nrc.2015.1 10.1261/rna.028639.111 10.1371/journal.pone.0139790 10.1002/dvdy.24548 10.1080/15384101.2016.1235847 |
| ContentType | Journal Article |
| Copyright | 2018 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. 2018 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. 2018. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: 2018 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. – notice: 2018 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. – notice: 2018. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM |
| DOI | 10.1111/cas.13642 |
| DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Database ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central ProQuest Health & Medical Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Biological Science Database Proquest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE CrossRef Publicly Available Content Database MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: ProQuest Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitleAlternate | SANCHEZ CALLE et al |
| EISSN | 1349-7006 |
| EndPage | 2100 |
| ExternalDocumentID | PMC6029823 29774630 10_1111_cas_13642 CAS13642 |
| Genre | reviewArticle Journal Article Review |
| GrantInformation_xml | – fundername: Uehara Memorial Foundation research – fundername: Japan Agency for Medical Research and Development funderid: 17cm0106217 h0002 – fundername: Naito Foundation research – fundername: Japan Agency for Medical Research and Development grantid: 17cm0106217 h0002 |
| GroupedDBID | --- .3N .55 .GA .Y3 05W 0R~ 10A 1OC 24P 29B 2WC 31~ 36B 3O- 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52W 52X 53G 5GY 5HH 5LA 5VS 66C 7.U 702 7PT 8-0 8-1 8-3 8-4 8-5 8FE 8FH 8UM 930 A01 A03 AAHHS AAZKR ABCQN ABEML ACCFJ ACCMX ACSCC ACXQS ADBBV ADKYN ADPDF ADZMN ADZOD AEEZP AENEX AEQDE AFBPY AFEBI AFFNX AFKRA AFPKN AFZJQ AIWBW AJBDE ALMA_UNASSIGNED_HOLDINGS ALUQN AOIJS AVUZU BAWUL BBNVY BCNDV BENPR BFHJK BHPHI BY8 CAG CCPQU COF CS3 D-6 D-7 D-E D-F DIK DR2 DU5 E3Z EBS EJD EMB EMOBN EX3 F00 F01 F04 F5P FIJ GODZA GROUPED_DOAJ HCIFZ HF~ HOLLA HYE HZI HZ~ IAO IHR IPNFZ ITC IX1 J0M K.9 K48 KQ8 LC2 LC3 LH4 LK8 LP6 LP7 LW6 M7P MK4 N04 N05 N9A O9- OIG OK1 OVD P2P P2X P2Z P4B P4D PIMPY PROAC Q11 ROL RPM RX1 SJN SUPJJ SV3 TEORI UB1 W8V WIN WOW WQJ WRC WXI X7M XG1 ZXP ~IA ~WT 7X7 88E 8FI 8FJ AAFWJ AAMMB AAYXX ABUWG AEFGJ AFFHD AGXDD AIDQK AIDYY CITATION FYUFA HMCUK M1P O8X PHGZM PHGZT PJZUB PPXIY PQGLB PSQYO UKHRP CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK AZQEC DWQXO GNUQQ K9. PKEHL PQEST PQQKQ PQUKI PRINS 7X8 PUEGO 5PM |
| ID | FETCH-LOGICAL-c5332-c5701a9da42c26500efc3ecec338fd7c3e6e8682a84b87f0491889347782e293 |
| IEDL.DBID | BENPR |
| ISICitedReferencesCount | 504 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000437108500002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1347-9032 1349-7006 |
| IngestDate | Tue Nov 04 02:01:59 EST 2025 Fri Sep 05 12:37:56 EDT 2025 Tue Oct 07 07:01:18 EDT 2025 Thu Apr 03 07:02:31 EDT 2025 Tue Nov 18 22:23:48 EST 2025 Sat Nov 29 02:46:56 EST 2025 Wed Jan 22 16:27:12 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 7 |
| Keywords | tumor suppressors long non-coding RNA tumor drivers tumor plasticity epithelial-to-mesenchymal transition |
| Language | English |
| License | Attribution-NonCommercial 2018 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c5332-c5701a9da42c26500efc3ecec338fd7c3e6e8682a84b87f0491889347782e293 |
| Notes | Funding information Japan Agency for Medical Research and Development (AMED; P‐CREATE; 17cm0106217h0002); The Uehara Memorial Foundation research grant; The Naito Foundation research grant. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 Japan Agency for Medical Research and Development (AMED; P‐CREATE; 17cm0106217h0002); The Uehara Memorial Foundation research grant; The Naito Foundation research grant. |
| ORCID | 0000-0002-0776-9918 0000-0002-1127-5822 0000-0001-8386-4645 |
| OpenAccessLink | https://www.proquest.com/docview/2248496431?pq-origsite=%requestingapplication% |
| PMID | 29774630 |
| PQID | 2248496431 |
| PQPubID | 4378882 |
| PageCount | 8 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6029823 proquest_miscellaneous_2041627783 proquest_journals_2248496431 pubmed_primary_29774630 crossref_citationtrail_10_1111_cas_13642 crossref_primary_10_1111_cas_13642 wiley_primary_10_1111_cas_13642_CAS13642 |
| PublicationCentury | 2000 |
| PublicationDate | July 2018 |
| PublicationDateYYYYMMDD | 2018-07-01 |
| PublicationDate_xml | – month: 07 year: 2018 text: July 2018 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: Tokyo – name: Hoboken |
| PublicationTitle | Cancer science |
| PublicationTitleAlternate | Cancer Sci |
| PublicationYear | 2018 |
| Publisher | John Wiley & Sons, Inc John Wiley and Sons Inc |
| Publisher_xml | – name: John Wiley & Sons, Inc – name: John Wiley and Sons Inc |
| References | 2017; 40 2017; 8 2010; 464 2018; 247 2010; 465 2016; 76 2016; 32 2005; 63 2016; 30 2012; 18 2012; 489 2016; 37 2017; 9 2016; 35 2013; 9 2010; 23 2017; 31 2015; 47 2018; 8 2013; 14 2017; 36 2017; 39 2013; 12 2016; 1859 2015; 44 2017; 163 2013; 154 2010; 2 2014; 7 2016; 48 2007; 25 2016; 46 2014; 54 2007; 26 2018; 36 2010; 34 2014; 512 2015; 6 2010; 39 2017; 21 2015; 10 2016; 10 2016; 124 2017; 292 2014; 110 2011; 3 2016; 17 2014; 111 2016; 16 2007; 12 2018; 20 2016; 164 2015; 26 2016; 6 2016; 7 2018; 17 2014; 507 2012; 2 2015; 556 2017; 17 2017; 16 2013; 73 2017; 12 2018 2011; 43 2018; 16 2016; 69 2014; 31 2016; 22 e_1_2_8_28_1 Mao T (e_1_2_8_36_1) 2017; 12 Lin Y (e_1_2_8_55_1) 2017; 9 Li Y (e_1_2_8_77_1) 2018; 8 e_1_2_8_24_1 e_1_2_8_47_1 e_1_2_8_26_1 e_1_2_8_49_1 e_1_2_8_68_1 Ke H (e_1_2_8_30_1) 2016; 10 e_1_2_8_3_1 Zhang M (e_1_2_8_76_1) 2017; 21 e_1_2_8_81_1 e_1_2_8_5_1 e_1_2_8_7_1 e_1_2_8_9_1 e_1_2_8_20_1 e_1_2_8_43_1 e_1_2_8_66_1 e_1_2_8_22_1 e_1_2_8_45_1 e_1_2_8_64_1 e_1_2_8_62_1 e_1_2_8_41_1 e_1_2_8_60_1 e_1_2_8_17_1 e_1_2_8_19_1 e_1_2_8_13_1 e_1_2_8_59_1 e_1_2_8_15_1 e_1_2_8_38_1 e_1_2_8_57_1 e_1_2_8_70_1 e_1_2_8_32_1 e_1_2_8_78_1 e_1_2_8_11_1 e_1_2_8_34_1 e_1_2_8_53_1 e_1_2_8_51_1 e_1_2_8_74_1 e_1_2_8_72_1 Zheng HT (e_1_2_8_48_1) 2014; 7 e_1_2_8_29_1 e_1_2_8_25_1 e_1_2_8_27_1 e_1_2_8_69_1 e_1_2_8_2_1 e_1_2_8_80_1 e_1_2_8_4_1 e_1_2_8_6_1 e_1_2_8_8_1 e_1_2_8_21_1 e_1_2_8_42_1 e_1_2_8_67_1 e_1_2_8_23_1 e_1_2_8_44_1 e_1_2_8_65_1 e_1_2_8_63_1 e_1_2_8_40_1 Jin Y (e_1_2_8_46_1) 2017; 21 e_1_2_8_61_1 e_1_2_8_18_1 e_1_2_8_39_1 e_1_2_8_14_1 e_1_2_8_35_1 e_1_2_8_16_1 e_1_2_8_37_1 e_1_2_8_58_1 e_1_2_8_79_1 e_1_2_8_10_1 e_1_2_8_31_1 e_1_2_8_56_1 e_1_2_8_12_1 e_1_2_8_33_1 e_1_2_8_54_1 e_1_2_8_75_1 e_1_2_8_52_1 e_1_2_8_73_1 e_1_2_8_50_1 e_1_2_8_71_1 |
| References_xml | – volume: 7 start-page: 62886 year: 2016 end-page: 62897 article-title: Long non‐coding RNA PVT1 activates hepatic stellate cells through competitively binding microRNA‐152 publication-title: Oncotarget – volume: 6 start-page: 6520 year: 2015 article-title: Genome‐wide profiling of p53‐regulated enhancer RNAs uncovers a subset of enhancers controlled by a lncRNA publication-title: Nat Commun – volume: 20 start-page: 492 year: 2018 end-page: 502 article-title: GUARDIN is a p53‐responsive long non‐coding RNA that is essential for genomic stability publication-title: Nat Cell Biol – volume: 489 start-page: 101 year: 2012 end-page: 108 article-title: Landscape of transcription in human cells publication-title: Nature – volume: 124 start-page: 649 year: 2016 end-page: 658 article-title: Long noncoding RNA PVT1 promotes cervical cancer progression through epigenetically silencing miR‐200b publication-title: APMIS – volume: 556 start-page: 227 year: 2015 end-page: 234 article-title: Genome‐wide analysis of long noncoding RNA signature in human colorectal cancer publication-title: Gene – volume: 8 start-page: 81 year: 2018 end-page: 90 article-title: Long noncoding RNA NEAT1 promotes the metastasis of osteosarcoma via interaction with the G9a‐DNMT1‐Snail complex publication-title: Am J Cancer Res – volume: 21 start-page: 3176 year: 2017 end-page: 3184 article-title: LncRNA MALAT1 promotes proliferation and metastasis in epithelial ovarian cancer via the PI3K‐AKT pathway publication-title: Eur Rev Med Pharmacol Sci – volume: 7 start-page: 40418 year: 2016 end-page: 40436 article-title: Functional and prognostic significance of long non‐coding RNA MALAT1 as a metastasis driver in ER negative lymph node negative breast cancer publication-title: Oncotarget – volume: 31 start-page: 1095 year: 2017 end-page: 1108 article-title: Neat1 is a p53‐inducible lincRNA essential for transformation suppression publication-title: Genes Dev – volume: 43 start-page: 513 year: 2011 end-page: 518 article-title: Principles for the post‐GWAS functional characterization of cancer risk loci publication-title: Nat Genet – volume: 63 start-page: 187 year: 2005 end-page: 197 article-title: Genome‐wide characterization of gene expression variations and DNA copy number changes in prostate cancer cell lines publication-title: Prostate – volume: 36 start-page: 310 year: 2018 article-title: High expression of long noncoding RNA NORAD indicates a poor prognosis and promotes clinical progression and metastasis in bladder cancer publication-title: Urol Oncol – volume: 9 start-page: 407 year: 2013 end-page: 411 article-title: Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer publication-title: Mol BioSyst – volume: 76 start-page: 2626 year: 2016 end-page: 2636 article-title: The ribonucleic complex HuR‐MALAT1 represses CD133 expression and suppresses epithelial‐mesenchymal transition in breast cancer publication-title: Cancer Res – volume: 35 start-page: 479 year: 2016 end-page: 487 article-title: Knockdown of long non‐coding RNA HOTAIR inhibits proliferation and invasiveness and improves radiosensitivity in colorectal cancer publication-title: Oncol Rep – volume: 3 start-page: 994 year: 2011 end-page: 1013 article-title: Role of p53 in cell death and human cancers publication-title: Cancers (Basel) – volume: 12 start-page: 261 year: 2013 end-page: 266 article-title: Clinical significance of long intergenic noncoding RNA‐p21 in colorectal cancer publication-title: Clin Colorectal Cancer – volume: 73 start-page: 1180 year: 2013 end-page: 1189 article-title: The noncoding RNA MALAT1 is critical regulator of the metastasis phenotype of lung cancer cells publication-title: Cancer Res – volume: 14 start-page: 699 year: 2013 end-page: 712 article-title: RNA in unexpected places: long non‐coding RNA functions in diverse cellular contexts publication-title: Nat Rev Mol Cell Biol – volume: 34 start-page: 148 year: 2010 end-page: 153 article-title: CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes publication-title: Leuk Res – volume: 6 start-page: 34043 year: 2016 article-title: Paraspeckles modulate the intranuclear distribution of paraspeckle‐associated Ctn RNA publication-title: Sci Rep – volume: 6 start-page: 41045 year: 2015 end-page: 41055 article-title: LncRNA MALAT1 enhances oncogenic activities of EZH2 in castration‐resistant prostate cancer publication-title: Oncotarget – volume: 2 start-page: a000687 year: 2010 article-title: Paraspeckles publication-title: Cold Springs Harb Prespect Biol – volume: 164 start-page: 69 year: 2016 end-page: 80 article-title: Noncoding RNA NORAD regulates genomic stability by sequestering PUMILLO proteins publication-title: Cell – volume: 47 start-page: 199 year: 2015 end-page: 208 article-title: The landscape of long noncoding RNAs in the human transcriptome publication-title: Nat Genet – volume: 110 start-page: 164 year: 2014 end-page: 171 article-title: Amplification of PVT‐1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers publication-title: Br J Cancer – volume: 16 start-page: 137 year: 2017 end-page: 138 article-title: NEAT1‐containing paraspeckles: central hubs in stress response and tumor formation publication-title: Cell Cycle – volume: 465 start-page: 1033 year: 2010 end-page: 1038 article-title: A coding‐independent function of gene and pseudogene mRNAs regulates tumor biology publication-title: Nature – volume: 16 start-page: 78 year: 2018 end-page: 89 article-title: Divergent activity of the pseudogene PTENP1 in ER‐positive and negative breast cancer publication-title: Mol Cancer Res – volume: 48 start-page: 1298 year: 2016 end-page: 1299 article-title: p53 partners with RNA in the DNA damage response publication-title: Nat Genet – volume: 163 start-page: 177 year: 2017 end-page: 190 article-title: High PTEN gene expression is a negative prognostic marker in human primary breast cancers with preserved p53 function publication-title: Breast Cancer Res Treat – volume: 12 start-page: 215 year: 2007 end-page: 229 article-title: Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas publication-title: Cancer Cell – volume: 48 start-page: 1370 year: 2016 end-page: 1376 article-title: An inducible long noncoding RNA amplifies DNA damage signaling publication-title: Nat Genet – volume: 6 start-page: 38414 year: 2016 article-title: MALAT1 and HOTAIR long non‐coding RNAs play opposite role in estrogen‐mediated transcriptional regulation in prostate cancer cells publication-title: Sci Rep – volume: 30 start-page: 34 year: 2016 end-page: 51 article-title: Differentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA loss publication-title: Genes Dev – volume: 69 start-page: 76 year: 2016 end-page: 81 article-title: Long non‐coding RNA chromogenic in situ hybridization signal pattern correlation with breast tumor pathology publication-title: J Clin Pathol – volume: 7 start-page: 95 year: 2014 end-page: 115 article-title: Pivotal role of pervasive neoplastic and stromal cells reprogramming in circulating tumor cells dissemination and metastatic colonization publication-title: Cancer Microenviron – volume: 17 start-page: 5 year: 2018 article-title: Paracrine and epigenetic control of CAF‐induced metastasis: the role of HOTAIR stimulated by TGF‐ß1 secretion publication-title: Mol Cancer – volume: 44 start-page: 71 year: 2015 end-page: 81 article-title: Suppression of hepatocellular carcinoma by baculovirus‐mediated expression of long non‐coding RNA PTENP1 and MicroRNA regulation publication-title: Biomaterials – volume: 507 start-page: 462 year: 2014 end-page: 470 article-title: A promoter‐level mammalian expression atlas publication-title: Nature – volume: 154 start-page: 26 year: 2013 end-page: 46 article-title: lincRNAs: genomics, evolution, and mechanisms publication-title: Cell – volume: 46 start-page: 1137 year: 2016 end-page: 1144 article-title: lincRNA‐p21 inhibits invasion and metastasis of hepatocellular carcinoma through Notch signaling‐induced epithelial‐mesenchymal transition publication-title: Hepatol Res – volume: 32 start-page: 390 year: 2016 end-page: 392 article-title: NORAD: defender of the Genome publication-title: Trends Genet – year: 2018 article-title: LncRNA NORAD contributes to colorectal cancer progression by inhibition of miR‐202‐5p publication-title: Oncol Res – volume: 12 start-page: 245 year: 2017 end-page: 257 article-title: ULK1 can suppress or promote tumor growth under different conditions publication-title: Autophagy – volume: 7 start-page: 3174 year: 2014 end-page: 3181 article-title: High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer publication-title: Int J Clin Exp Pathol – volume: 36 start-page: 981 year: 2017 end-page: 994 article-title: PRC2 is dispensable for HOTAIR‐mediated transcriptional repression publication-title: EMBO J – volume: 40 start-page: 370 year: 2017 end-page: 374 article-title: NORAD expression is associated with adverse prognosis in esophageal squamous cell carcinoma publication-title: Oncol Res Treat – volume: 17 start-page: 1 year: 2017 end-page: 8 article-title: LincRNA‐p21 predicts favorable clinical outcome and impairs tumorigenesis in diffuse large B cell lymphoma patients treated with R‐CHOP chemotherapy publication-title: Clin Exp Med – volume: 39 start-page: 925 year: 2010 end-page: 938 article-title: The nuclear‐retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation publication-title: Mol Cell – volume: 2 start-page: 111 year: 2012 end-page: 123 article-title: The lncRNA Malat 1 is dispensable for mouse development but its transcription plays a cis‐regulatory role in the adult publication-title: Cell Rep – volume: 23 start-page: 583 year: 2010 end-page: 584 article-title: Smoke and miRrors: pseudogenes tricking miRNAs publication-title: Pigment Cell Melanoma Res – volume: 25 start-page: 5341 year: 2007 end-page: 5344 article-title: p53: it has it all, but will it make it to the clinic as a marker in bladder cancer? publication-title: J Clin Oncol – volume: 31 start-page: 1839 year: 2014 article-title: LincRNA‐p21 enhances the sensitivity of radiotherapy for human colorectal cancer by targeting the Wnt/β‐catenin signaling pathway publication-title: Oncol Rep – volume: 10 start-page: 11 year: 2016 end-page: 17 article-title: NEAT1 is required for survival of breast cancer cells through FUS and miR‐548 publication-title: Gene Regul Syst Bio – volume: 39 start-page: 1010428317727539 year: 2017 article-title: Genetic polymorphisms of HOTAIR gene are associated with the risk of breast cancer in a sample of southeast Iranian population publication-title: Tumor Biol – volume: 8 start-page: 1604 year: 2017 article-title: Decoding critical long non‐coding RNA in ovarian cancer epithelial‐to‐mesenchymal transition publication-title: Nat Commun – volume: 8 start-page: 63813 year: 2017 end-page: 63824 article-title: Down regulation of lincRNA‐p21 contributes to gastric cancer development through Hippo‐independent activation of YAP publication-title: Oncotarget – volume: 10 start-page: e0139790 year: 2015 article-title: Long noncoding RNA MEG3 interacts with p53 protein and regulates partial p53 target genes in hepatoma cells publication-title: PLoS ONE – volume: 6 start-page: 27641 year: 2015 end-page: 27650 article-title: NEAT expression is associated with tumor recurrence and unfavorable prognosis in colorectal cancer publication-title: Oncotarget – volume: 6 start-page: 41194 year: 2015 end-page: 41203 article-title: Tetracycline‐inducible shRNA targeting long non‐coding RNA PVT1 inhibits cell growth and induces apoptosis in bladder cancer cells publication-title: Oncotarget – volume: 16 start-page: 819 year: 2017 end-page: 827 article-title: Long noncoding RNA PVT1 promotes EMT and cell proliferation and migration through downregulating p21 in pancreatic cancer cells publication-title: Technol Cancer Res Treat – volume: 26 start-page: 391 year: 2015 end-page: 402 article-title: Paradigm shifts in genomics through the FANTOM projects publication-title: Mamm Genome – volume: 54 start-page: 777 year: 2014 end-page: 790 article-title: LincRNA‐p21 activates p21 in cis to promote Polycomb target gene expression and to enforce the G1/S checkpoint publication-title: Mol Cell – volume: 22 start-page: 861 year: 2016 end-page: 868 article-title: p53 induces formation of NEAT1 lncRNA‐containing paraspeckles that modulate replication stress response and chemosensitivity publication-title: Nat Med – volume: 1859 start-page: 324 year: 2016 end-page: 338 article-title: Knockdown of long non‐coding RNA MALAT1 increases the blood‐tumor barrier permeability by up‐regulating miR‐140 publication-title: Biochim Biophys Acta – volume: 9 start-page: 3677 year: 2017 end-page: 3689 article-title: Polymorphisms of long non‐coding RNA HOTAIR with breast cancer susceptibility and clinical outcomes for a southeast Chinese Han population publication-title: Oncotarget – volume: 18 start-page: 738 year: 2012 end-page: 751 article-title: Identification of cis‐ and trans‐acting factors involved in the localization of MALAT‐1 noncoding NRA to nuclear speckles publication-title: RNA – volume: 17 start-page: 104 year: 2016 end-page: 113 article-title: Long noncoding RNA MEG3 is downregulated in cervical cancer and affects cell proliferation and apoptosis by regulating miR‐21 publication-title: Cancer Biol Ther – volume: 26 start-page: 851 year: 2007 end-page: 858 article-title: A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas publication-title: Oncogene – volume: 37 start-page: 11733 year: 2016 end-page: 11741 article-title: The long non‐coding RNA NEAT1 regulates epithelial to mesenchymal transition and radioresistance in through miR‐204/ZEB1 axis in nasopharyngeal carcinoma publication-title: Tumor Biol – volume: 247 start-page: 405 year: 2018 end-page: 431 article-title: Tumor microenvironment and noncoding RNAs as co‐drivers of epithelial‐mesenchymal transition and cancer metastasis publication-title: Dev Dyn – volume: 464 start-page: 1071 year: 2010 end-page: 1076 article-title: Long non‐coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis publication-title: Nature – volume: 292 start-page: 82 year: 2017 end-page: 99 article-title: MEG3 long noncoding RNA contributes to the epigenetic regulation of epithelial‐mesenchymal transition in lung cancer cell lines publication-title: J Biol Chem – volume: 21 start-page: 1020 year: 2017 end-page: 1026 article-title: lncRNA NEAT1 is closely related with progression of breast cancer via promoting proliferation and EMT publication-title: Eur Rev Med Pharmacol Sci – volume: 512 start-page: 82 year: 2014 end-page: 86 article-title: PVT1 dependence in cancer with MYC copy‐number increase publication-title: Nature – volume: 36 start-page: 942 year: 2017 end-page: 955 article-title: The Snail repressor recruits EZH2 to specific genomic sites through the enrollment of the lncRNA HOTAIR in epithelial‐to‐mesenchymal transition publication-title: Oncogene – volume: 111 start-page: 736 year: 2014 end-page: 748 article-title: Long non‐coding RNA MALAT1 promotes tumor growth and metastasis in colorectal cancer through binding to SFPQ and releasing oncogene PTBP2 from SFPQ/PTBP2 complex publication-title: Br J Cancer – volume: 16 start-page: 43 year: 2016 end-page: 55 article-title: Somatic mosaicism: on the road to cancer publication-title: Nat Rev Cancer – ident: e_1_2_8_70_1 doi: 10.1136/jclinpath-2015-203275 – ident: e_1_2_8_62_1 doi: 10.1159/000464465 – ident: e_1_2_8_65_1 doi: 10.1038/bjc.2013.698 – ident: e_1_2_8_73_1 doi: 10.1111/hepr.12659 – volume: 7 start-page: 3174 year: 2014 ident: e_1_2_8_48_1 article-title: High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer publication-title: Int J Clin Exp Pathol – ident: e_1_2_8_61_1 doi: 10.3727/096504018x15190844870055 – ident: e_1_2_8_45_1 doi: 10.1158/0008-5472.CAN-15-2018 – ident: e_1_2_8_50_1 doi: 10.1038/sj.onc.1209846 – ident: e_1_2_8_34_1 doi: 10.1111/j.1755-148X.2010.00748.x – ident: e_1_2_8_72_1 doi: 10.1074/jbc.M116.750950 – ident: e_1_2_8_43_1 doi: 10.1016/j.celrep.2012.06.003 – ident: e_1_2_8_10_1 doi: 10.1016/j.ccr.2007.07.027 – ident: e_1_2_8_64_1 doi: 10.1038/nature13311 – ident: e_1_2_8_53_1 doi: 10.3892/or.2015.4397 – ident: e_1_2_8_11_1 doi: 10.1038/ng.840 – ident: e_1_2_8_21_1 doi: 10.1007/s10238-015-0396-8 – volume: 8 start-page: 81 year: 2018 ident: e_1_2_8_77_1 article-title: Long noncoding RNA NEAT1 promotes the metastasis of osteosarcoma via interaction with the G9a‐DNMT1‐Snail complex publication-title: Am J Cancer Res – ident: e_1_2_8_3_1 doi: 10.1038/nature13182 – ident: e_1_2_8_80_1 doi: 10.18632/oncotarget.11709 – ident: e_1_2_8_6_1 doi: 10.1038/nrm3679 – ident: e_1_2_8_67_1 doi: 10.1111/apm.12555 – ident: e_1_2_8_15_1 doi: 10.1002/pros.20158 – ident: e_1_2_8_58_1 doi: 10.1038/srep38414 – ident: e_1_2_8_68_1 doi: 10.1007/s12307-014-0158-2 – ident: e_1_2_8_14_1 doi: 10.1038/ncomms7520 – ident: e_1_2_8_22_1 doi: 10.3892/or.2014.3047 – ident: e_1_2_8_4_1 doi: 10.1007/s00335-015-9593-8 – ident: e_1_2_8_25_1 doi: 10.1038/ng.3702 – volume: 9 start-page: 3677 year: 2017 ident: e_1_2_8_55_1 article-title: Polymorphisms of long non‐coding RNA HOTAIR with breast cancer susceptibility and clinical outcomes for a southeast Chinese Han population publication-title: Oncotarget doi: 10.18632/oncotarget.23343 – ident: e_1_2_8_37_1 doi: 10.1158/1541-7786.MCR-17-0207 – ident: e_1_2_8_49_1 doi: 10.1016/j.bbagrm.2015.11.008 – ident: e_1_2_8_2_1 doi: 10.1038/nature11233 – ident: e_1_2_8_44_1 doi: 10.18632/oncotarget.9622 – volume: 21 start-page: 3176 year: 2017 ident: e_1_2_8_46_1 article-title: LncRNA MALAT1 promotes proliferation and metastasis in epithelial ovarian cancer via the PI3K‐AKT pathway publication-title: Eur Rev Med Pharmacol Sci – ident: e_1_2_8_12_1 doi: 10.1200/JCO.2007.13.1904 – ident: e_1_2_8_60_1 doi: 10.1016/j.cell.2015.12.017 – ident: e_1_2_8_40_1 doi: 10.1158/0008-5472.CAN-12-2850 – ident: e_1_2_8_66_1 doi: 10.18632/oncotarget.5880 – ident: e_1_2_8_28_1 doi: 10.1101/cshperspect.a000687 – ident: e_1_2_8_39_1 doi: 10.1101/gad.270959.115 – ident: e_1_2_8_5_1 doi: 10.1038/ng.3192 – ident: e_1_2_8_17_1 doi: 10.1080/15384047.2015.1108496 – ident: e_1_2_8_23_1 doi: 10.1016/j.clcc.2013.06.003 – ident: e_1_2_8_59_1 doi: 10.1016/j.tig.2016.04.002 – ident: e_1_2_8_51_1 doi: 10.18632/oncotarget.5728 – ident: e_1_2_8_78_1 doi: 10.1038/onc.2016.260 – ident: e_1_2_8_35_1 doi: 10.1016/j.biomaterials.2014.12.023 – ident: e_1_2_8_19_1 doi: 10.1016/j.leukres.2009.06.019 – ident: e_1_2_8_31_1 doi: 10.18632/oncotarget.4737 – ident: e_1_2_8_81_1 doi: 10.1177/1533034617700559 – volume: 10 start-page: 11 year: 2016 ident: e_1_2_8_30_1 article-title: NEAT1 is required for survival of breast cancer cells through FUS and miR‐548 publication-title: Gene Regul Syst Bio – ident: e_1_2_8_79_1 doi: 10.1186/s12943-018-0758-4 – ident: e_1_2_8_7_1 doi: 10.1016/j.cell.2013.06.020 – ident: e_1_2_8_20_1 doi: 10.1016/j.molcel.2014.04.025 – ident: e_1_2_8_47_1 doi: 10.1038/bjc.2014.383 – ident: e_1_2_8_32_1 doi: 10.1101/gad.284661.116 – ident: e_1_2_8_27_1 doi: 10.1038/srep34043 – ident: e_1_2_8_54_1 doi: 10.1038/nature08975 – ident: e_1_2_8_18_1 doi: 10.1039/c2mb25386k – ident: e_1_2_8_26_1 doi: 10.1038/s41556-018-0066-7 – ident: e_1_2_8_38_1 doi: 10.1007/s10549-017-4160-5 – ident: e_1_2_8_42_1 doi: 10.1016/j.molcel.2010.08.011 – ident: e_1_2_8_33_1 doi: 10.1038/nature09144 – ident: e_1_2_8_63_1 doi: 10.1016/j.urolonc.2018.02.019 – ident: e_1_2_8_13_1 doi: 10.3390/cancers3010994 – ident: e_1_2_8_24_1 doi: 10.1038/ng.3673 – ident: e_1_2_8_52_1 doi: 10.1016/j.gene.2014.11.060 – ident: e_1_2_8_56_1 doi: 10.1177/1010428317727539 – volume: 21 start-page: 1020 year: 2017 ident: e_1_2_8_76_1 article-title: lncRNA NEAT1 is closely related with progression of breast cancer via promoting proliferation and EMT publication-title: Eur Rev Med Pharmacol Sci – volume: 12 start-page: 245 year: 2017 ident: e_1_2_8_36_1 article-title: ULK1 can suppress or promote tumor growth under different conditions publication-title: Autophagy – ident: e_1_2_8_71_1 doi: 10.1038/s41467-017-01781-0 – ident: e_1_2_8_57_1 doi: 10.15252/embj.201695335 – ident: e_1_2_8_29_1 doi: 10.1038/nm.4135 – ident: e_1_2_8_74_1 doi: 10.18632/oncotarget.19130 – ident: e_1_2_8_75_1 doi: 10.1007/s13277-015-4773-4 – ident: e_1_2_8_9_1 doi: 10.1038/nrc.2015.1 – ident: e_1_2_8_41_1 doi: 10.1261/rna.028639.111 – ident: e_1_2_8_16_1 doi: 10.1371/journal.pone.0139790 – ident: e_1_2_8_69_1 doi: 10.1002/dvdy.24548 – ident: e_1_2_8_8_1 doi: 10.1080/15384101.2016.1235847 |
| SSID | ssj0036494 |
| Score | 2.6792023 |
| SecondaryResourceType | review_article |
| Snippet | Since comprehensive analysis of the mammalian genome revealed that the majority of genomic products are transcribed in long non‐coding RNA (lncRNA), increasing... Since comprehensive analysis of the mammalian genome revealed that the majority of genomic products are transcribed in long non‐coding RNA (lnc RNA ),... Since comprehensive analysis of the mammalian genome revealed that the majority of genomic products are transcribed in long non-coding RNA (lncRNA), increasing... |
| SourceID | pubmedcentral proquest pubmed crossref wiley |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 2093 |
| SubjectTerms | Androgens Animals Apoptosis Autophagy Bladder cancer Breast cancer Cancer Cell cycle Cell growth Cell proliferation Chromatin remodeling Colorectal cancer Deoxyribonucleic acid DNA DNA methylation Enhancers Epigenetics epithelial‐to‐mesenchymal transition Gene expression Genomes Humans long non‐coding RNA Metastases Neoplasms - genetics Ovarian cancer Prostate cancer Proteins Review Ribonucleic acid RNA RNA, Long Noncoding - genetics Transcription tumor drivers tumor plasticity Tumor suppression tumor suppressors |
| SummonAdditionalLinks | – databaseName: Wiley Online Library Open Access dbid: 24P link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1JS8QwFH64IV7cl7pRxYOXQrNMk-JpEMWLw6AevJU0pjggrczi2Z_gb_SX-F43ZlBB8FJS8tqk7-UlX5Z-D-AsCpURjneCzKGTS6MM-ZwIRGQlN4ZAtiyDTaheTz8-xv05uGj-han4IdoFN_KMsr8mBzfpaMrJKSQYEwif52GRMaEpbgOX_aYbxpy4imgrVRCHgte0QnSMp310djD6hjC_H5ScBrDlCHS99q-6r8NqDTz9btVSNmDO5ZuwfFtvrW8Bo-Upiljk04HDkV9k_kuBd3mRf75_2ILGOP-u1_UHuW-pqQy34eH66uHyJqjjKQQWQR3HqwqZiZ-M5JYjMgtdZoWzzuI0NXtSmI6cjjQ3WqZaZWgnphHOSIUowiEs2IEFLNPtgS9tR_I0zkxqUqm4S1HdjHONyk4ZThg9OG_0mtiaa5xCXrwkzZwDNZCUGvDgtBV9rQg2fhI6bIyT1D42ShB8aEl0YsyDkzYbvYO2PEzuignKhAg4OX6A8GC3smVbCifoG4nQAzVj5VaAmLdnc_LBc8nAHRFxPcd3npdW_r3iyWX3vkzs_130AFYQlenqTPAhLIyHE3cES_ZtPBgNj8tG_gXiivx0 priority: 102 providerName: Wiley-Blackwell |
| Title | Emerging roles of long non‐coding RNA in cancer |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fcas.13642 https://www.ncbi.nlm.nih.gov/pubmed/29774630 https://www.proquest.com/docview/2248496431 https://www.proquest.com/docview/2041627783 https://pubmed.ncbi.nlm.nih.gov/PMC6029823 |
| Volume | 109 |
| WOSCitedRecordID | wos000437108500002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1349-7006 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0036494 issn: 1347-9032 databaseCode: DOA dateStart: 20140101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 1349-7006 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0036494 issn: 1347-9032 databaseCode: M7P dateStart: 19880101 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1349-7006 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0036494 issn: 1347-9032 databaseCode: 7X7 dateStart: 19880101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1349-7006 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0036494 issn: 1347-9032 databaseCode: BENPR dateStart: 19880101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Publicly Available Content Database customDbUrl: eissn: 1349-7006 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0036494 issn: 1347-9032 databaseCode: PIMPY dateStart: 19880101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVWIB databaseName: Wiley Online Library Free Content customDbUrl: eissn: 1349-7006 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0036494 issn: 1347-9032 databaseCode: WIN dateStart: 20030101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell – providerCode: PRVWIB databaseName: Wiley Online Library Open Access customDbUrl: eissn: 1349-7006 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0036494 issn: 1347-9032 databaseCode: 24P dateStart: 20030101 isFulltext: true titleUrlDefault: https://authorservices.wiley.com/open-science/open-access/browse-journals.html providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwEB7BLqp6KYU-SKGrgDhwiUgcEzsntCAQHIgiQGJ7ihyvo660SmAX-vs74zhbVjwuvVi2PIrjmbH9eTyaAdhPQqFiw46CyuAi50ooWnNxECeaM6UIZHObbEJkmRyN0twZ3ObOrbLbE-1GPW402cgP8aiRnIJHRcf3DwFljaLXVZdCYxX6FKmM96B_cpbl191eHCc8bdPachGkYcxcbCHy5aGUYhESsOUT6QXMfOkt-RzF2mPofP1_J_AZPjkA6g9bjdmAFVNvwocr98T-BQ7JTEWZi3xyPJz7TeVPG2zVTR3ohk46_zob-pPa16Qws69we352e3oRuKwKgUZox7AUYaTSseJMM8Rnoal0bLTReFmtxgLriZGJZEryUooKpRVJBDVcIJYwCA6-QQ9HNFvgc33EWZlWqlQlF8yUyO-IMYncLiO8Nnpw0DG20C7iOCW-mBbdzQNlUFgZeLC3IL1vw2y8RrTTcbZwK21e_GOrB7uLblwj9PChatM8IU2IsJPhBGIPvrfCXIzCCAAnceiBWBLzgoDiby_31JPfNg53QuHrGX7zwCrE2z9enA5vbOXH-zPYho-Ix2TrDbwDvcfZk_kJa_rP42Q-G8Aq4zmWYiRsKQdO2wfWkDAgt1Xs7-eXV_kvbN1dZn8Bmz0GYg |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3dT9RAEJ8QMMoL-AkVxNVowktz7XTpbh-MuSAEAlyM3sO9Ndu9bbyEtHAfEP8o_0dn-qUX1DcefGm22Um77Xz9ZjudAXgXB8pEDg_83JGSS6MM61zkR7GVaAyDbFk1m1CDgR6Nks8r8KP9F4bTKlubWBnqcWl5j7xHrkZLLh4Vfry69rlrFH9dbVto1GJx5r7fUsg2-3D6ifj7HvH4aHh44jddBXxL0AbpqILQJGMj0SLhk8DlNnLWWQrW8rGicex0rNFomWmV02pDTU5dKvKlDrn2Eln8NTLjijPI1KiL76JYJnUPXan8JIiwKWTEiUPcvywkAlx2f3cw7d3UzN8hc-Xzjjf_s7f1GDYacC36tTY8gRVXPIWHF036wDPo8RYcd2USnFQ5E2UuLks6K8rCtyV7cfFl0BeTQlhWhulzGN7Hal_AKt3RbYOQ9kBiluQmM5lU6DJib4ioiblZSCGxB_stH1PbVFPnph6XaRtVEcvTiuUevO1Ir-oSIn8i2m0ZmTZWZJb-4qIHb7pp0n_-qGMKVy6IJiBIjfQAkQdbtex0d0EG93EUeKCWpKoj4NriyzPF5FtVYzzm0vxI19yv5O_vC08P-1-rwct_P8FreHQyvDhPz08HZzuwTrhT11nPu7A6ny7cK3hgb-aT2XSvUioB6T2L5U9TZ1eN |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1LT9wwEB4hqFAvLX1BWtqaqpW4RJtMTOwcULU8VkXQaEU5cIscryNWQgnd5SF-Gv-uM3lsWdH2xqGXyJFHiZ15fbYnMwCf40CZyOGWXzhScmmUYZ2L_Ci2Eo1hkC3rYhMqTfXpaTJcgLvuXxgOq-xsYm2oR5XlPfIeuRotOXlU2CvasIjh3uDrxU-fK0jxSWtXTqMRkUN3e0PLt-n2wR7x-gviYP9k95vfVhjwLcEcpKsKQpOMjESLhFUCV9jIWWdp4VaMFLVjp2ONRstcq4JGHmpy8FKRX3XIeZjI-i8pwhikXEs7--nwuHMDUSyTpqKuVH4SRNimNeIwIq5mFhIBzjvDBwj3YaDmfQBde8DB8__4263AsxZ2i36jJy9gwZUvYfl7G1jwCnq8Ocf1mgSHW05FVYjziu7KqvRtxf5dHKd9MS6FZTWZvIaTxxjtG1ikN7o1ENJuScyTwuQmlwpdTqwOETUxOg9psezBZsfTzLZ51rncx3nWrbeI_VnNfg8-zUgvmuQifyJa75iatfZlmv3mqAcbs26yDHzcY0pXXRFNQGAbaQKRB6uNHM3eggz74yjwQM1J2IyAs47P95Tjszr7eMxJ-5GeuVnL4t8Hnu32f9SNt_-ewUdYJmnMjg7Sw3fwlACpbsKh12HxcnLl3sMTe305nk4-tBomIHtkufwFUuNhrg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Emerging+roles+of+long+non%E2%80%90coding+RNA+in+cancer&rft.jtitle=Cancer+science&rft.au=Sanchez+Calle%2C+Anna&rft.au=Kawamura%2C+Yumi&rft.au=Yamamoto%2C+Yusuke&rft.au=Takeshita%2C+Fumitaka&rft.date=2018-07-01&rft.pub=John+Wiley+and+Sons+Inc&rft.issn=1347-9032&rft.eissn=1349-7006&rft.volume=109&rft.issue=7&rft.spage=2093&rft.epage=2100&rft_id=info:doi/10.1111%2Fcas.13642&rft_id=info%3Apmid%2F29774630&rft.externalDocID=PMC6029823 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1347-9032&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1347-9032&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1347-9032&client=summon |